Interesting Clinical Trial Immune Cell Stimulation
I did a final consult with a Radiation Oncologist at UNM Cancer today. He thought I would be a good candidate for this. It looks interesting but would be with traditional Photon versus Proton. I am leaning towards Proton, but as a promising 3rd phase trial I thought I would share with everyone. See my Proton post for my details if needed.
ProstAtak®Trial- Newly Diagnosed Intermediate and High Prostate Cancer http://www.advantagene.com/
Prevention of prostate cancer recurrence in intermediate and high risk patients is the goal of Advantagene’s Phase 3 study. Results to date from our early clinical studies in prostate cancer, including newly diagnosed prostate cancer, have been extremely promising. We are currently conducting a randomized, fully blinded, placebo controlled Phase 3 clinical study examining GMCI (ProstAtak®) in combination with standard radiation therapy in patients with newly diagnosed, intermediate to high risk localized prostate cancer. This 711 patient study is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA.
Study Co-chairs:
Peter Scardino, MD,
Chairman of the Department of Surgery
Memorial Sloan Kettering Cancer Center
Theodore DeWeese, MD
Chairman, Department of Radiation Oncology and Molecular Radiation Sciences
Johns Hopkins Medical Institute
To download a copy of patient brochure, Click ProstAtak™ patient brochure
Comments
-
Photon vs Proton
Hi SantaZia,
I know if I ever need radiation it will be with Proton not Photon. The following quote is from a web site that specializes in Proton treaments.
"Proton therapy is precise. Unlike traditional (photon) radiation, protons travel directly to the site of the tumor and stop. They deliver radiation to the tumor but do not continue through the body. As a result, healthy tissues near the tumor do not receive doses of radiation that they don’t need. This benefit is particularly important for tumors located in or near vital organs" .
No exit damage sounds good to me...........................
Dave 3+4
0 -
About those protons
The (often used) statement that protons will just hit the cancer can't be true. Even if all protons were to stop at the cancerous site, they still have to travel through tissue to get there.
See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080851/
for a more serious discussion of this topic.
0 -
ProtonsOld Salt said:About those protons
The (often used) statement that protons will just hit the cancer can't be true. Even if all protons were to stop at the cancerous site, they still have to travel through tissue to get there.
See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080851/
for a more serious discussion of this topic.
Thanks Old Salt!
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.7K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 308 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 395 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 236 Multiple Myeloma
- 7.1K Ovarian Cancer
- 59 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.4K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 727 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards